FCC ID: Q6ZHEM716BT2 Blood Pressure Monitor

Confidential B

*Due to the size of product, the statement required by FCC 15.19(a) will be printed on users manual. The FCC Identifier FCC ID is 4.0 point or larger. The labels are laser-engraved, so the letters do not fade easily and the labels themselves do not peel off. IC:XXXXX-XXXXXXXX will be replaced by IC:10623A-HEM716BT2. FCC ID: XXX-XXXXXXX will be replaced by FCC ID:Q6ZHEM716BT2.

Confidential B

*Due to the size of product, the statement required by FCC 15.19(a) will be printed on users manual. The FCC Identifier FCC ID is 4.0 point or larger. The labels are laser-engraved, so the letters do not fade easily and the labels themselves do not peel off. FCC ID: XXX-XXXXXXX will be replaced by FCC ID:Q6ZHEM716BT2.

OoOmRON Federal Communications Commission Authorization and Evaluation Division 7435 Oakland Mills Road Columbia, MD 21046 FCC ID: Q6ZHEM716BT2 OMRON HEALTHCARE Co.,Ltd (the applicant) certifies that the equipment for which authorization is sought is not covered equipment prohibited from receiving an equipment authorization pursuant to section 2.903 of the FCC rules. OMRON HEALTHCARE Co.,Ltd (the applicant) certifies that, as of the date of the filing of the application, the applicant is not identified on the Covered List as an entity producing covered equipment and is not an affiliate or subsidiary of an entity identified on the Covered List. Toshiaki Yuasa OMRON HEALTHCARE Co.,Ltd Sincerely yours, RE: CFR 47 2.911 (d)(5) Attestation

Date: June 15, 2023 Federal Communications Commission Authorization and Evaluation Division 7435 Oakland Mills Road Columbia, MD 21046 RE: CFR 47 2.911 (d)(7) FCC US Agent Letter of Attestation FCC ID: Q6ZHEM716BT2 Grantee FRN: 0021928791 To whom it may concern:

FCC US Agent Contact Person: Lisa Fields Company Name: Omron Healthcare, Inc FRN: 0033512021 Company Address: 2895 Greenpoint Parkway Hoffman Estates ILLINOIS 60169 USA Email: lisa.fields@omron.com This letter is to confirm that we have accepted the responsibility to act as US Agent on behalf of OMRON HEALTHCARE Co.,Ltd (the applicant) for the above referenced FCC ID. We are aware of the requirements and responsibilities of the applicants agent for service of process as outlined in the FCC section 2.911(d)(7) and Report and Order FCC 22-84 paragraph 63. Sincerely yours, Signature:

Lisa Fields Omron Healthcare, Inc

OMRON Federal Communications Commission Authorization and Evaluation Division 7435 Oakland Mills Road Columbia, MD 21046 RE: CFR 47 2.911 (d)(7) Agent Designation Attestation FCC ID: Q6ZHEM716BT2 Grantee FRN: 0021928791 OMRON HEALTHCARE Co.,Ltd (the applicant) as required by section 2.911(d)(7), designates the following agent, located in the United States, for purposes of acting as the applicants agent for service of process. The applicant acknowledges that they will maintain an agent for no less than one year after the grantee has terminated all marketing and importation or the conclusion of any Commission-related proceeding involving the equipment. The applicant further acknowledges their responsibility under CFR 47 2.929(c) to inform the FCC whenever the agent information changes. U.S. Agent Information:

Contact Person: Lisa Fields Company Name: Omron Healthcare, Inc FRN: 0033512021 Company Address: 2895 Greenpoint Parkway Hoffman Estates ILLINOIS 60169 USA Email: lisa.fields@omron.com Toshiaki Yuasa OMRON HEALTHCARE Co.,Ltd Sincerely yours,

OMRON UL Verification Services Inc. 47173 Benicia Street, Fremont, CA 94538 Applicant: OMRON HEALTHCARE Co.,Ltd FCC ID: Q6ZHEM716BT2 Date: June 15, 2023 This authorization is valid until further written notice from the applicant. The application for the subject equipment has not been submitted to another TCB for certification. To whom it may concern:

We, the undersigned, hereby authorize Akiko Nishimura of Consumer, Medical & Information Technologies Division, UL Japan, Inc. to act on our behalf in all manners relating to application for equipment authorization, including signing of all documents relating to these matters. Any and all acts carried out by UL Japan, Inc. on our behalf shall have the same effect as acts of our own. We, the undersigned, hereby certify that we are not subject to a denial of federal benefits, that includes FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. 862. Sincerely Yours, Toshiaki Yuasa OMRON HEALTHCARE Co.,Ltd Letter of Authorization

OMRON UL Verification Services Inc. 47173 Benicia Street, Fremont, CA 94538 Applicant: OMRON HEALTHCARE Co.,Ltd FCC ID : Q6ZHEM716BT2 To whom it may concern:

Please be advised that the following information is to be held confidential on behalf of us, referring to the FCC rules 0.457 and 0.459:

Request for Confidentiality The application contains technical information which we deem to be trade secrets and proprietary. If made public, the information might be used to the disadvantage of the applicant in the market place. Thank you for your attention to this matter. Block Diagram Theory of Operation Schematics Parts List Toshiaki Yuasa OMRON HEALTHCARE Co.,Ltd Date: June 15, 2023

OMRON Request for Short-Term Confidentiality The application contains technical information, which we deem to be trade secrets and proprietary. If made public, the information might be used to the disadvantage of the applicant in the market place. Thank you for your attention to this matter External Photos Internal Photos Test Setup Photos User Manual UL Verification Services Inc. 47173 Benicia Street, Fremont, CA 94538 Applicant: OMRON HEALTHCARE Co.,Ltd FCC ID : Q6ZHEM716BT2 To whom it may concern:

Please be advised that the following information is to be held in confidence for 180 days from the date of the Grant of Equipment Authorization based on the FCC rules 0.457 and 0.459:

Toshiaki Yuasa OMRON HEALTHCARE Co.,Ltd Date: June 15, 2023